Assessing adherence by combining the test of adherence to inhalers with pharmacy refill records

28Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Background: The Global Initiative for Asthma (GINA) recommends the concurrent use of self-report and pharmacy refill data to assess treatment adherence. However, clinical evidence to support this combined approach is limited. Objective: To determine nonadherence to inhaler medication based on a validated questionnaire (Test of Adherence to Inhalers; TAI) and prescription refill data in a community sample of patients with chronic obstructive pulmonary disease (COPD) or asthma. Secondarily, we sought to determine the degree of concordance between these two measures. Methods: Cross-sectional, observational multicenter study in patients with asthma or COPD. Sociodemographic and clinical data were obtained from clinical records. Refill data were retrieved from electronic pharmacy databases. Participants completed the 12-item TAI during a single visit as part of routine care. Nonadherence was defined as TAI <50 or <80% pharmacy refill rate (PRR) in the previous 6 months. Results: A total of 816 patients (mean age, 60) were included. Nonadherence rates were 58.1% (TAI) and 28.6% (PRR) compared with 64.6% for the combined data (P

Cite

CITATION STYLE

APA

Plaza, V., Giner, J., Curto, E., Alonso-Ortiz, M. B., Orue, M. I., Vega, J. M., & Cosío, B. G. (2021). Assessing adherence by combining the test of adherence to inhalers with pharmacy refill records. Journal of Investigational Allergology and Clinical Immunology, 31(1), 58–64. https://doi.org/10.18176/jiaci.0461

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free